James Arthur Bristol, Director at Deciphera Pharmaceuticals, Inc. (DCPH), sold 37,766 shares at $28.01 ($1.1M) on 2019-02-14, disclosed to the SEC on 2019-02-19.
Open-market sale of $1.1M DCPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.01 | 1,101 | $31K | 2.9% |
| 2 | $28.01 | 1,101 | $31K | 2.9% |
| 3 | $28.04 | 17,782 | $499K | 47.1% |
| 4 | $28.04 | 17,782 | $499K | 47.1% |
| Total | $28.04 avg | 37,766 | $1.1M | 100% |
| Filing → |
| DCPH | SELL | 2021-04-14 | $1.3M | — | Filing → |
| DCPH | SELL | 2021-01-20 | $352K | — | Filing → |
| DCPH | SELL | 2020-10-13 | $2.5M | — | Filing → |